Lessee, Operating Lease, Liability, to be Paid, Year Two in USD of Vitro Biopharma, Inc. from Q4 2022 to Q2 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
-
Summary
-
Vitro Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two history and change rate from Q4 2022 to Q2 2025.
- Vitro Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Jul 2025 was $84.6K, a 49.3% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)